12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga·07/29/2026 21:06:04
Listen to the news
Gainers
- Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session.
- Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at $3.0 million.
- Corcept Therapeutics (NASDAQ:CORT) stock increased by 19.05% to $110.66. The market value of their outstanding shares is at $10.1 billion. As per the news, the Q2 earnings report came out today.
- Aspire Biopharma Holdings (NASDAQ:ASBP) stock increased by 14.08% to $6.4. The company's market cap stands at $9.3 million.
- Myriad Genetics (NASDAQ:MYGN) stock rose 13.29% to $5.71. The market value of their outstanding shares is at $502.4 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares rose 12.76% to $0.06. The company's market cap stands at $2.2 million.
Losers
- Teladoc Health (NYSE:TDOC) shares fell 24.3% to $6.95 during Wednesday's after-market session. The company's market cap stands at $1.6 billion. As per the press release, Q2 earnings came out today.
- Inovio Pharmaceuticals (NASDAQ:INO) stock fell 20.25% to $0.83. The market value of their outstanding shares is at $84.7 million.
- SciSparc (NASDAQ:SPRC) shares fell 15.63% to $7.67. The company's market cap stands at $3.0 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) stock decreased by 12.77% to $1.26. The company's market cap stands at $1.3 million.
- TransCode Therapeutics (NASDAQ:RNAZ) shares declined by 10.87% to $4.51. The market value of their outstanding shares is at $5.2 million.
- Citius Pharmaceuticals (NASDAQ:CTXR) stock decreased by 10.02% to $0.51. The market value of their outstanding shares is at $13.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.